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Abstract
Human milk decreases the risk of necrotising enterocolitis (NEC), a severe gastrointestinal disease that occurs in 5–10% of preterm infants. The
prebiotic and immune-modulatory effects of milk oligosaccharides may contribute to this protection. Preterm pigs were used to test whether
infant formula enriched with α1,2-fucosyllactose (2'-FL, the most abundant oligosaccharide in human milk) would beneﬁt gut microbial
colonisation and NEC resistance after preterm birth. Caesarean-delivered preterm pigs were fed formula (Controls, n 17) or formula with
5 g/l 2'-FL (2'-FL, n 16) for 5 d; eight 2'-FL pigs (50%) and twelve Controls (71%) developed NEC, with no difference in lesion scores (P= 0·35);
2'-FL pigs tended to have less anaerobic bacteria in caecal contents (P= 0·22), but no difference in gut microbiota between groups were
observed by ﬂuorescence in situ hybridisation and 454 pyrosequencing. Abundant α1,2-fucose was detected in the intestine with no
difference between groups, and intestinal structure (villus height, permeability) and digestive function (hexose absorption, brush border
enzyme activities) were not affected by 2'-FL. Formula enrichment with 2'-FL does not affect gut microbiology, digestive function or NEC
sensitivity in pigs within the ﬁrst few days after preterm birth. Milk 2'-FL may not be critical in the immediate postnatal period of preterm
neonates when gut colonisation and intestinal immunity are still immature.
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Preterm birth is associated with immature organ functions
and greater risk of postnatal morbidities such as necrotising
enterocolitis (NEC), a life-threatening intestinal disease that
occurs in 5–10% of preterm infants. The risk of NEC increases
when infants are fed a milk replacer instead of human milk(1),
probably because human milk contains growth-promoting,
immune-stimulating and antimicrobial components. Among
these, human milk oligosaccharides (HMO) are fucosylated and
sialylated carbohydrate structures that are speculated to mod-
ulate mucosal immunity, growth and bacterial colonisation(2).
With concentrations of upto 23 g/l(3), HMO represent the third
most-abundant group of solids in human milk(4), but they are
almost absent in cow’s milk(2). HMO are largely indigestible(5)
but may have important intestinal luminal functions. Among the
many different HMO, α1,2-fucosyllactose (2'-FL) is among the
most abundant (2·5 g/l)(6,7), and it has been shown to increase
the growth of Biﬁdobacteria, while suppressing Clostridia sp.
and Enterobacteria sp.(8,9). Further, 2'-FL shares structural
homology with fucosylated H-antigens on the intestinal
epithelium to which various pathogenic bacteria adhere,
including Escherichia coli F18 that is pathogenic to weanling
pigs(10,11). 2'-FL decreases adhesion of pathogenic bacteria
in vitro(12–14), and 2'-FL levels in human milk are inversely
related to the incidence of infectious diarrhoea with Campylo-
bacter in infants(15).
NEC is often associated with overgrowth of potentially
harmful bacteria such as Clostridium sp., Klebsiella sp., E. coli,
Pseudomonas sp. and Staphylococcus sp.(16). Potentially, 2'-FL
can reduce the risk of NEC by acting in parallel with intestinal
fucosylated glycans to improve gut colonisation via prebiotic
actions and inhibition of speciﬁc harmful bacteria. Preterm
infants that do not express H-antigen show increased NEC and
death rates, indicating the importance of intestinal glycan
fucosylation(17). 2'-FL may also modulate immune signalling by
the gut mucosa, as demonstrated for sialylated HMO(2). Immune
modulation can explain the protection against NEC-like lesions
and increased overall survival of neonatal rats after supple-
mentation with a sialylated HMO(18), the same HMO associated
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* Corresponding author: P. T. Sangild, fax +45 3533 2469, email pts@sund.ku.dk
British Journal of Nutrition (2016), 116, 834–841 doi:10.1017/S0007114516002646
© The Authors 2016
http:/www.cambridge.org/core/terms. http://dx.doi.org/10.1017/S0007114516002646
Downloaded from http:/www.cambridge.org/core. DTU Library - Tech Info Ctr of Denmark, on 07 Oct 2016 at 08:33:28, subject to the Cambridge Core terms of use, available at
with decreased NEC incidence in infants from HIV-infected
mothers(19). HMO, including 2'-FL, may increase intestinal
maturation(20) and modulate immune signalling pathways(21), in
part via inhibiting the CD14-mediated, endotoxin-induced
inﬂammation(22).
Preterm milk contains particularly high levels of 2'-FL
(7 g/l)(3), suggesting a protective role in preterm infants.
We tested the hypothesis that dietary supplementation with
physiological doses (5 g/l) of 2'-FL would decrease NEC inci-
dence and intestinal lesions by modulating bacterial colonisa-
tion and stimulating mucosal growth and digestive function in
newborn preterm pigs. Preterm pigs show a high incidence of
NEC-like lesions when fed increasing amounts of enteral milk
diets, especially formula, during the ﬁrst 1–2 weeks after birth.
Intestinal structure and function were investigated on day 5,
after a relatively fast transition from parenteral to enteral
feeding. Hence, the present study focused on the effects of
a 2'-FL-enriched formula on the immature intestine during the
immediate postnatal period.
Methods
Animal protocol and experimental design
In total, thirty-three pigs from two sows (Large White×Danish
Landrace) were delivered by caesarean section at 90% gestation
and reared individually in temperature- and O2-regulated
incubators. While they still remained sedated after the caesarean
section, the pigs were ﬁtted with umbilical (4F; Portex)
and orogastric catheters (6F; Pharmaplast). Mother’s serum
(12ml/kg during the ﬁrst 24 h) was provided via the umbilical
catheter for passive immunisation. For 2 d, the pigs received
parenteral nutrition (PN, 4–6ml/kg per h, Nutriﬂex lipid plus;
Braun) with added amino acids (Vamin; Fresenius Kabi).
As a supplement to PN, minimal enteral nutrition (MEN) with
the respective enteral diets was provided for the ﬁrst 2 d
(2–3ml/kg per 3 h). To standardise bacterial colonisation, an
oral inoculation of maternal faecal bacteria (2·5× 104 colony-
forming units (cfu)) was given on day 1. The PN-MEN period
was followed by full enteral feeding with infant formula from
day 3 to 5 (15ml/kg per 3 h of Pepdite, Maxipro and Liquigen-
MCT; SHS International; 4151 kJ/l energy; 64 g/l protein;
47 g/l carbohydrate with 90% maltodextrin; 61 g/l fat(23)). The
pigs were stratiﬁed according to birth weight and sex into pigs
fed Control formula (n 17) or 2'-FL formula (n 16) containing
freeze-dried 2'-fucosyllactose (Glycosyn) at 5 g/l. The animal
procedures followed our standard protocol(24), and were
approved by the National Committee on Animal Experimenta-
tion, Denmark, based on the ARRIVE (Animal Research:
Reporting of In Vivo Experiments) Guidelines.
Necrotising enterocolitis evaluation and tissue collection
Pigs were checked every 3 h for NEC symptoms including
bloody diarrhoea, lethargy, respiratory distress and abdominal
distension, until euthanasia and tissue collection on day 5.
However, pigs that developed NEC symptoms were immediately
euthanised (pentobarbitone, 60mg/kg, i.v.) and tissue samples
were collected. At necropsy, the stomach, proximal, middle
and distal regions of the small intestine, and the colon were
scored for NEC lesions according to our standard macroscopic
evaluation system: 1= normal, 2= local hyperaemia and
oedema, 3=hyperaemia, extensive oedema and local
haemorrhage, 4= extensive haemorrhage, 5= local necrosis
and pneumatosis intestinalis and 6= extensive necrosis and
pneumatosis intestinalis. NEC was deﬁned as a score of
at least three in at least one gastrointestinal region(24). Organs
were weighed, and tissues from the three small intestinal
regions were collected and snap-frozen for later analyses;
three sections equally dispersed along the small intestine
(proximal, middle and distal intestine at 17, 50 and 83% from
the stomach) were formalin ﬁxed and parafﬁn embedded
for histology, ﬂuorescence in situ hybridisation (FISH) and
lectin hybridisation.
Digestive function, mucosal integrity and intestinal
fucosylation
Galactose absorption was measured in pigs before transition to
full enteral feeding using blood samples collected 20min after
the administration of an oral bolus of 15ml/kg of 5% galactose
and 2% mannitol(25). The combined lactose digestive and
absorptive capacity was measured in pigs 36 h after transition to
full enteral feeding as plasma galactose 30min after a 15ml/kg
bolus of 15% lactose. Intestinal permeability was assessed as
the postmortem urine ratio of lactulose:mannitol(26) after oral
administration of 0·5 g/kg lactulose and 0·3 g/kg mannitol 4 h
before euthanasia. The above-mentioned analyses were per-
formed for all pigs, whereas the tissue analyses were performed
only for twenty-one pigs from one litter (n 10 and 11 for 2'-FL
and Control pigs, respectively).
Mucosal disaccharidase activities (maltase, sucrase, lactase)
and peptidase activities (aminopeptidase N and A (ApN
and ApA) and dipeptidyl peptidase IV (DPPIV)) were measured
in tissue homogenates of the three regions of the small
intestine(27). Mucosa was scraped from 10-cm fresh sections of
the proximal, middle or distal small intestine to determine
dry weight proportions. Villus height was measured by
scanning pictures of parafﬁn-embedded sections of the distal
small intestine (ArrayWoRx microarray scanner; Applied
Precision) using ImageJ version 1.44 (US National Institutes
of Health).
Intestinal α1,2-fucosylation was measured on parafﬁn-
embedded cross-sections (3 µm) from the proximal, middle and
distal small intestine by hybridisation with α1,2-fucose-speciﬁc
lectin, Ulex Europaeus Agglutinin I (UEA-I; Vector Laboratories),
labelled with green ﬂuorescein isothiocyanate. Sections were
evaluated using an Axioimager M1 epiﬂuorescence microscope
(Carl Zeiss). Sections were scored for α1,2-fucose binding on the
basis of a green ﬂuorescence signal, where 1=none, 2= a few
positively stained goblet cells, 3= several positively stained
goblet cells, mainly in the crypt area, or moderate luminal green
ﬂuorescence, 4= abundant, positively stained goblet cells along
the entire mucosal lining and 5= abundant, positively stained
goblet cells along the entire mucosal lining together with
extensive luminal ﬂuorescence.
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Microbiology
Caecal contents were plated on calf blood agar (SSI
Diagnostica), cultivated overnight under anaerobic conditions
and total anaerobic bacteria was enumerated. Microbial com-
positions of caecal contents and of the mucosa of the distal
small intestine were analysed by 454 pyrosequencing. Samples
were homogenised by bead beating for 2min/20Hz in a tissue
lyser (Qiagen). After DNA puriﬁcation using the Maxwell
platform (Promega), the V4–V5 region of the bacterial 16s
rDNA was ampliﬁed using bar-coded primers (519F
5'-CAGCAGCCGCGGTAATAC-3', 926R 5'-CCGTCAATTCCTTT
GAGTTT-3'). DNA quantity and quality were analysed in
a Agilent 2100 Bioanalyzer (Agilent Technologies) using the
Agilent RNA 1000 Nano Kit, and 50 ng DNA from each of the
thirty-nine samples (twenty-one from small intestinal tissues
and eighteen from caecal contents) were pooled for sequencing
on a 454 Roche GS FLX titanium platform at LGC Genomics
following the manufacturer’s protocols (Roche). The data set
was analysed in the Quantitative Insight Into Microbial Ecology
(QIIME) open-source package (version 1.7.0). Raw data
underwent quality control, de-noising, chimera ﬁltering and
Operational Taxonomic Unit (OTU) picking(28), and clustering
at 97% relatedness using UCLAST. Representative sequences
from each cluster were aligned with pyNAST and subjected to
the Ribosomal Database Project. Alpha diversity was calculated,
as observed species and Chao1 and Shannon indices for OTU
tables were uniﬁed to 2000 sequences per sample. Principal
coordinate analysis (PCoA) plots were generated with the Jack-
knifed Beta Diversity workﬂow-based ten subsampled OTU
tables and 85% of sequences taken for each jackknifed subset.
Bacterial abundance in situ was evaluated using the same
tissues as above after hybridisation with Alexa ﬂuor
555-labelled oligonucleotide probes (Euroﬁns MWG Operon)
targeting general bacterial 16S rRNA (5'-GCTGCCTCCC
GTAGGAGT-3')(29). Bacterial micro-colonies were visualised by
scanning, and sections were given a FISH-score based on the
red ﬂuorescence signal: 1=no/very few bacteria, 2= a few
bacteria spread in the intestinal lumen or tissue, 3= several
colonies in the intestinal lumen or tissue and 4= extensive and
abundant bacteria in the intestinal lumen and/or tissue. Selected
tissue sections were further analysed by confocal microscopy
(Zeiss LSM 710; Carl Zeiss microimaging) for detailed associa-
tions between colonising bacteria and intestinal mucosa.
Calculations and statistical analyses
Sample size for the study population was determined on the
basis of a power calculation using the estimated means and
standard deviations for NEC incidence across sixteen previous
preterm pig studies (69 (SEM 21)%, n 210). In these studies,
the most effective diets were interventions with lactose(30),
colostrum(24) and oral antibiotics(31) that reduced the basic NEC
rates by 70–90%. On the basis of this background, an expected
effect of HMO supplementation was set to a reduction in the
NEC rate by 30%. Consequently, the required sample size for
80% power was seventeen. Differences in NEC incidence were
tested between treatment groups using Fisher’s exact test. Other
data were analysed using R version 3.0.1. Differences in weight
gain, NEC scores, sugar absorption, intestinal permeability and
mucosal proportions were tested using the lmer function of
linear mixed model analysis with sow as the random variable
and with treatment, birth weight and sex as ﬁxed variables.
After model reduction, additionally measured parameters were
compared by two-way ANOVA to evaluate the treatment effect.
The lm function was used to test villus height, enzyme activity,
cfu counts and FISH, with treatment, birth weight and sex as
ﬁxed variables. For pyrosequencing data, group differences in
PCoA plots were evaluated by analysis of similarities (QIIME)
using weighted and unweighted uniFrac distance metrics
generated from rareﬁed OTU tables (excluding seven samples
with <2000 reads). A t test (Monte Carlo, 999 permutations,
QIIME) was used to calculate differences in alpha diversity.
Differences in the ﬁve, most-dominant OTU were tested using
the lmer function in R, where treatment, birth weight and sex
were ﬁxed variables. Normal distribution of all measured
parameters was tested by plotting the residuals and by the
qq-plot using the qqnorm function. All values are presented as
means and standard errors, unless otherwise stated. For all
analyses, P< 0·05 was used as the critical level of signiﬁcance.
Results
Clinical outcomes
Of the thirty-three preterm pigs, on day 5, eight 2'-FL pigs (50%)
and twelve Controls (71%) were diagnosed with NEC lesions
(P= 0·30). The average lesion scores in the small intestine were
1·5 (SEM 0·1) v. 1·6 (SEM 0·1) for 2'-FL pigs and Controls, respec-
tively (P= 0·77), and the average colon lesion scores were 1·9
(SEM 0·3) v. 2·3 (SEM 0·3), respectively (P= 0·35, Fig. 1). There were
no differences between groups (means across treatments,
P= 0·15–0·80) for birth weight (908 (SEM 38) g), relative weight
gain (−0·62 (SEM 17·8) g/kg) and relative weights (g/kg) for
stomach (7·6 (SEM 0·3)), small intestine (37·2 (SEM 1·3)), colon
(11·4 (SEM 0·6)), heart (7·9 (SEM 0·3)), lungs (25·8 (SEM 1·3)), liver
(28·4 (SEM 0·8)), kidneys (9·8 (SEM 0·2)) and spleen (1·6 (SEM 0·1)).
Digestive function, mucosal integrity and fucosylation
Supplementation with 2'-FL did not inﬂuence the initial galac-
tose absorptive capacity on day 3 (499 (SEM 79) µmol/l across
0
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6
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Stomach Prox Mid Dist Colon
Fig. 1. Necrotising enterocolitis (NEC) scores in five gastrointestinal tract regions
shown as a scatter plot where each dot within a region represents one pig. NEC is
defined as a score of at least three in at least one gastrointestinal region ( ).
There were no differences between α1,2-fucosyllactose (2'-FL, ) and Control
pigs ( ). Prox, proximal small intestine; mid, middle small intestine; dist, distal small
intestine.
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groups, P= 0·66) or on day 5 (39·8 (SEM 9·6), P= 0·70). Likewise,
the activities of six brush border enzymes (U/g) were not
affected by 2'-FL supplementation (Fig. 2), neither in the small
intestine (sucrase: 0·19 (SEM 0·01), maltase: 2·55 (SEM 0·25),
lactase: 15·01 (SEM 1·41), ApN: 6·19 (SEM 0·33), ApA: 4·11
(SEM 0·31), DPPIV: 1·68 (SEM 0·07), P= 0·13–0·90 between
groups) nor in the colon (sucrase: 0·27 (SEM 0·04), maltase: 1·31
(SEM 0·08), lactase: 2·68 (SEM 0·37), ApN: 0·65 (SEM 0·06), ApA:
0·47 (SEM 0·15), DPPIV: 0·41 (SEM 0·03), P= 0·07–0·91 between
groups). Similarly, there was no effect of 2'-FL on the lactulose:
mannitol ratio (0·12 (SEM 0·03), P= 0·56 between groups),
mucosal proportion (71 (SEM 1)% dry weight, P= 0·80–0·94) or
villus height (553 (SEM 30) µm, P= 0·26–0·97). In situ hybridi-
sation with ﬂuorescence-labelled UEA-1 revealed high levels of
endogenous α1,2'-fucose (Fig. 3(a) and (b)), with no difference
between 2'-FL pigs and Controls (score 3·4 (SEM 0·4) v. 3·0
(SEM 0·4), respectively, P= 0·44). Goblet cells and the mucus
layer were highly stained in most pigs (Fig. 3(a)), whereas
in some pigs α1,2-fucose was found in enterocyte membranes
(Fig. 3(b)).
Microbiology
Caecal content cultures showed a trend towards less abundance
of anaerobic bacteria in 2'-FL pigs but without signiﬁcance
(1·6 (SEM 0·6)× 1010 v. 2·7 (SEM 0·6)× 1010 cfu/ml, P= 0·22). FISH
analyses of bacteria adhering to the intestinal mucosa revealed
that the majority of pigs were densely colonised with bacteria
that often appeared to have invaded the mucosa (Fig. 3(c)
and (d)). However, the bacterial density was independent of
treatment, and no differences in FISH-score were detected
between 2'-FL pigs and Controls (2·3 (SEM 0·2) across six
intestinal regions, P= 0·40–0·94).
Pyrosequencing resulted in 11 804 (SEM 996) sequences per
sample (n 39) with no difference detected between intestinal
contents and tissues and between the two treatments (P= 0·2
and 0·4, respectively). More separate OTU were identiﬁed in
tissue than in caecal contents (21·1 (SEM 2·6) v. 11·8 (SEM 0·7),
respectively, P< 0·05), supported by a higher alpha diversity in
tissue v. contents as well (P< 0·05). However, there was no
difference in alpha diversity between 2'-FL and Control
pigs (P= 0·83). Lactobacillus, Enterococcus, Turicibacter,
Streptococcus and Clostridiaceae (all Firmicutes) were the ﬁve
most-dominant OTU, accounting for 94% of the total sequences
in intestinal tissue and 98% in caecal contents (Fig. 4(a)). The
relative abundance of Lactobacillus was lower in tissue than in
caecal contents (P= 0·06), whereas the abundance of more rare
OTU was greater in tissues than in caecal contents. This was
especially true for 2' FL pigs, where rare OTU were 0·5% in
caecal contents and 8·5% in tissues, whereas in Controls these
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Fig. 2. Brush-border enzyme activity (values are means, with their standard errors) for sucrase, maltase, lactase, aminopeptidase N (ApN), aminopeptidase A (ApA)
and dipeptidyl peptidase IV (DPPIV). There were no differences between α1,2-fucosyllactose (2'-FL, ) and Control pigs ( ). Prox, proximal small intestine; mid,
middle small intestine; dist, distal small intestine.
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values were 3·2 and 4·2%, respectively. The relative distribution
of the ﬁve dominant taxa tended to differ between 2'-FL and
Control pigs in both tissues and caecal contents (Fig. 4(a)), but
only Enterococcus in caecal contents showed signiﬁcantly
different proportions between 2'-FL and Control pigs (P< 0·05;
P= 0·12 for tissue). PCoA plots, both weighted (quantitative)
and unweighted (qualitative), did not reveal any differences
between 2'-FL and Control pigs, neither for tissue nor for caecal
contents (P= 0·2–0·5, Fig. 4(b)).
Discussion
NEC is a life-threatening intestinal inﬂammatory disease in
preterm infants, which is closely associated with the progres-
sion of intestinal bacterial colonisation and enteral feeding,
especially using formula. Human milk is rich in HMO, whereas
formula is based on cow’s milk and contains limited amounts of
oligosaccharides. The concentration of the most abundant HMO
in human milk, 2'-FL, is particularly high following preterm
birth(3), and this HMO has been shown to inhibit colonisation
with pathogens(12–14,17,32) and enhance the proliferation of
putative beneﬁcial bacteria such as Biﬁdobacteria(8,9). In addi-
tion, 2'-FL and other HMO may exert microbiota-independent
maturation of gut immunity and digestive functions(18,20–22) and
this could be particularly important for newborn preterm
infants. Contrary to our hypothesis, we now show that addition
of 2'-FL to formula at a dose of 5 g/l has limited effects on
bacterial colonisation, mucosal fucosylation, mucosal structure,
digestive function and NEC sensitivity within the ﬁrst 5 d after
preterm birth in pigs. Whether 2'-FL supports intestinal
maturation in the long term, when gut bacterial colonisation
and intestinal immunity become more mature, remains to
be investigated.
The chosen 2'-FL concentration (5 g/l) was within the normal
range found in human milk(3,6). A concentration of 2 g/l was
previously found to increase the growth of beneﬁcial bacteria
and to decrease the density of potentially harmful bacteria(9). In
term newborn pigs, doses upto 10 g/l 2'-FL were well tolerated
and a concentration of minimum 5g/l was required to inhibit
adhesion of the porcine pathogen E. coli F18 to porcine
enterocytes in vitro(33). To make sure that all the (initially
sterile) caesarean-delivered pigs in this study were equipped
with the same initial culture of maternal bacteria, we provided
them with a small dose of faecal microbiota (104 cfu) from their
mother along with their ﬁrst formula feed. Nevertheless, the
subsequent microbiota that colonised the intestines of pigs
during the following days appeared minimally affected by 5 g/l
2'-FL in the formula. The concentration of 2'-FL in human milk is
highest in colostrum and declines thereafter(6). Likewise, the
amounts are higher in milk from mothers delivering preterm
(7 g/l)(3) compared with term milk (2 g/l)(6). Although this
may indicate an increased need for 2'-FL just after birth, and
particularly preterm birth, variation in milk constituents with
gestational age and lactation length do not necessarily reﬂect
physiological needs. In humans, secretion of 2'-FL depends
on maternal genotype and about 20% of Caucasian women are
(a) (b)
(c) (d)
Fig. 3. Representative tissue sections of the small intestine hybridised with green fluorescein isothiocyanate-labelled lectin specific for α1,2'-fucose (a, b). Mainly
goblet cells and the mucus layer were stained positive for α1,2'-fucose in both treatment groups (a), but it was also incorporated in the enterocyte membranes of some
pigs (b). Representative tissue section of the small intestine hybridised with red fluorescence-labelled probes targeting 16S rRNA of general bacteria (c). Confocal
microscopy reveals close association between the gut epithelium and bacteria and even bacterial invasion of the enterocytes (d).
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non-secretors(7). Although infants of low-secretor mothers
appear to be at higher risk of diarrhoea(15), a relationship
between NEC risk and maternal genotype or 2'-FL concentration
has not been clearly established, although in one study infants
with low secretor status had a 10-fold increased risk of
NEC-related death and an 18-fold increased risk of death due
to sepsis(17).
In preterm pigs, we observed an abundant presence of
endogenous α1,2'-fucose in the intestinal mucosa, as shown by
lectin hybridisation, but we did not ﬁnd any relation among
these levels and the degree of NEC lesions, type of microbiota
or other intestinal parameters. Thus, it is possible that the
beneﬁcial effects of fucosylated compounds along the mucosal
lining remain inadequate in the preterm newborn pig to protect
against the pro-inﬂammatory effects of bacterial colonisation
when fed formula devoid of the bioactive compounds of the
mother’s milk. Further, addition of 2'-FL did not appear to
increase the tissue scores for α1,2'-fucose, although there was a
tendency towards decreased NEC incidence and score in the
colon region. This, together with a tendency towards decreased
caecal bacterial density in 2'-FL pigs, indicates a marginal
beneﬁcial effect of 2'-FL supplementation for the colon.
It is possible that such an effect would not become fully
expressed until after gut bacterial colonisation becomes more
established and after a longer period of 2'-FL supplementation
of formula. Even though the number of pigs included is
sufﬁcient to secure appropriate power to the study, the pigs
were derived from only two litters, and inclusion of additional
litters may have strengthened a marginal beneﬁcial effect of
2'-FL. After the ﬁrst 5 d, there was no evidence of effects on
small intestinal growth, permeability, digestive function or
nutrient absorption. The FISH analyses revealed that bacteria
were closely associated with the small intestinal mucosa, and
dense bacterial colonisation of the enterocyte cytosol was also
shown. This colonisation was not altered by dietary 2'-FL
supplementation and did not correlate with endogenous
α1,2'-fucose or NEC lesions. The bacterial community that
inhabited the intestinal lumen and mucosa was not different
between 2'-FL and Control pigs, except that the relative
abundance of Enterococcus was higher in 2'-FL pigs. No
members of Biﬁdobacteria were detected by pyrosequencing,
and it is possible that the previously reported biﬁdogenic effect
of 2'-FL may be less relevant for pigs, as Biﬁdobacteria are not
a major genus in the porcine gut(34).
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An important consideration is whether the effects of HMO
and 2'-FL are species speciﬁc. The limited effects of dietary 2'-FL
on bacterial colonisation in preterm pigs are in contrast with
previous studies in infants(8–11,13,14,35) and in neonatal rats,
where a di-sialylated HMO decreased NEC severity(18). In both
rat and cow’s milk, sialylated HMO dominate, whereas porcine
milk contains more fucosylated compounds, as in human
milk, although the concentrations are lower and 2'-FL is not
detected(36). Hence, we cannot exclude that dietary 2'-FL is
less important for pigs, relative to humans, and that high
endogenous levels of α1,2'-fucose in the pig intestine from birth
make supply of 2'-FL via the enteral milk diet less critical. On
the other hand, it is also possible that the immature intestinal
structure, function, microbiology and immunology in the new-
born period make the effects of dietary 2'-FL less pronounced
at this time, both for preterm and term birth, and across the
different mammalian species.
Preterm pigs are born with a highly immature intestine,
resulting in spontaneous development of NEC lesions in a large
proportion of pigs following bacterial colonisation and formula
feeding(24). This makes the preterm pig a highly sensitive model
to investigate the mucosal responses to diet and microbial
factors in preterm infants. In the present study, NEC lesion
scores were relatively mild compared with some of our
previous studies, but this cannot explain that 2'-FL failed to
reduce NEC lesions and improve intestinal structure and func-
tion. Even if we only compare the severe NEC cases (NEC
scores 4–6), there were no signiﬁcant differences between 2'-FL
and Control pigs (38 v. 47%). As in neonatal intensive care
units, NEC incidence varies over time and is determined by
many factors other than diet and microbiota – for example,
gestational age at birth, host genetics and other co-morbidities
associated with preterm birth. In preterm pigs, NEC develops
relatively early after birth and with a higher frequency
compared with preterm infants, and early interventions may
therefore have higher effect in pigs relative to infants. On the
other hand, it is possible that the mild subclinical NEC-like
lesions that are frequently observed in preterm pigs at autopsy
(especially in the colon)(37) may also be present temporarily in
many infants that are never diagnosed with fulminant clinical
NEC (most often affecting the small intestine). We conclude that
addition of 2'-FL is unlikely to prevent the detrimental effects of
formula-feeding during the 1st week after birth in preterm
newborns. More studies on the species, age and diet depen-
dency of HMO are required before the addition of 2'-FL or other
HMO can be recommended for highly sensitive newborns.
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